BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23333498)

  • 21. Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells.
    Chaudhuri D; Orsulic S; Ashok BT
    Mol Cancer Ther; 2007 Jan; 6(1):334-45. PubMed ID: 17237292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma.
    Nihal M; Ahmad N; Mukhtar H; Wood GS
    Int J Cancer; 2005 Apr; 114(4):513-21. PubMed ID: 15609335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells.
    Kanematsu S; Uehara N; Miki H; Yoshizawa K; Kawanaka A; Yuri T; Tsubura A
    Anticancer Res; 2010 Sep; 30(9):3381-90. PubMed ID: 20944112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of Epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression.
    Yan C; Yang J; Shen L; Chen X
    Arch Gynecol Obstet; 2012 Feb; 285(2):459-67. PubMed ID: 21698451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
    Lee MH; Han DW; Hyon SH; Park JC
    Apoptosis; 2011 Jan; 16(1):75-85. PubMed ID: 20963498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effects of green tea extract and paclitaxel in the induction of mitochondrial apoptosis in ovarian cancer cell lines.
    Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Bakhshi A; Abazari O; Abbasi M; Khanicheragh P; Shabanzadeh M
    Gene; 2021 Jun; 787():145638. PubMed ID: 33848578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xiaoaiping injection enhances paclitaxel efficacy in ovarian cancer via pregnane X receptor and its downstream molecules.
    Zhang XQ; Ding YW; Chen JJ; Xiao X; Zhang W; Zhou L; Kong QW; Shi MZ; Yang J; Jiang B; Guo C; Han YL
    J Ethnopharmacol; 2020 Oct; 261():113067. PubMed ID: 32505840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
    Farabegoli F; Papi A; Bartolini G; Ostan R; Orlandi M
    Phytomedicine; 2010 Apr; 17(5):356-62. PubMed ID: 20149610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with β-elemene combined with paclitaxel inhibits growth, migration, and invasion and induces apoptosis of ovarian cancer cells by activation of STAT-NF-κB pathway.
    Xiaomeng F; Lei L; Jinghong A; Juan J; Qi Y; Dandan Y
    Braz J Med Biol Res; 2020; 53(6):e8885. PubMed ID: 32401925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTEN/AKT/mTOR signaling mediates anticancer effects of epigallocatechin‑3‑gallate in ovarian cancer.
    Qin J; Fu M; Wang J; Huang F; Liu H; Huangfu M; Yu D; Liu H; Li X; Guan X; Chen X
    Oncol Rep; 2020 Jun; 43(6):1885-1896. PubMed ID: 32236585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells.
    Sadava D; Whitlock E; Kane SE
    Biochem Biophys Res Commun; 2007 Aug; 360(1):233-7. PubMed ID: 17585882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin and epithelial ovarian cancer therapeutics.
    Patel S; Kumar L; Singh N
    Cell Oncol (Dordr); 2015 Oct; 38(5):365-75. PubMed ID: 26266765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arsenic trioxide and tetraarsenic oxide induce cytotoxicity and have a synergistic effect with cisplatin in paclitaxel-resistant ovarian cancer cells.
    Byun JM; Lee DS; Landen CN; Kim DH; Kim YN; Lee KB; Sung MS; Park SG; Jeong DH
    Acta Oncol; 2019 Nov; 58(11):1594-1602. PubMed ID: 31257975
    [No Abstract]   [Full Text] [Related]  

  • 34. Sulforaphane induces growth arrest and apoptosis in human ovarian cancer cells.
    Chuang LT; Moqattash ST; Gretz HF; Nezhat F; Rahaman J; Chiao JW
    Acta Obstet Gynecol Scand; 2007 Oct; 86(10):1263-8. PubMed ID: 17851821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy.
    Zhang G; Wang Y; Zhang Y; Wan X; Li J; Liu K; Wang F; Liu K; Liu Q; Yang C; Yu P; Huang Y; Wang S; Jiang P; Qu Z; Luan J; Duan H; Zhang L; Hou A; Jin S; Hsieh TC; Wu E
    Curr Mol Med; 2012 Feb; 12(2):163-76. PubMed ID: 22280355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.
    Spinella F; Rosanò L; Di Castro V; Decandia S; Albini A; Nicotra MR; Natali PG; Bagnato A
    Mol Cancer Ther; 2006 Jun; 5(6):1483-92. PubMed ID: 16818507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivo.
    Mao HL; Pang Y; Zhang X; Yang F; Zheng J; Wang Y; Liu P
    Oncol Rep; 2013 Feb; 29(2):515-22. PubMed ID: 23151974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cells.
    Griffin D; Wittmann S; Guo F; Nimmanapalli R; Bali P; Wang HG; Bhalla K
    Gynecol Oncol; 2003 Apr; 89(1):37-47. PubMed ID: 12694652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells.
    Meeran SM; Patel SN; Chan TH; Tollefsbol TO
    Cancer Prev Res (Phila); 2011 Aug; 4(8):1243-54. PubMed ID: 21411498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins.
    Yasmeen A; Beauchamp MC; Piura E; Segal E; Pollak M; Gotlieb WH
    Gynecol Oncol; 2011 Jun; 121(3):492-8. PubMed ID: 21388661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.